147
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Cost analysis of a disease management programme for adult Medicaid clients with schizophrenia

, PhD MS RPh, , PharmD, , BA, , BA, , BA, , MA & , BSM BSBA show all
Pages 411-426 | Accepted 18 Jul 2007, Published online: 28 Oct 2008

References

  • Goeree R, Farahati F, Burke N, et al. The economic burden of schizophrenia in Canada in 2004. Current Medical Research and Opinion 2005; 21: 2017–2028
  • Rupp A, Keith SJ. The costs of schizophrenia: assessing the burden. Psychiatric Clinics of North America 1993; 16: 413–423
  • Lehman AF, Steinwachs DM. Evidence-based psychosocial treatment practices in schizophrenia: lessons from the Patient Outcomes Research Team (PORT) project. Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry 2003; 31: 141–154
  • Lehman AF, Steinwachs DM. Patterns of usual care for schizophrenia: initial results of the Patient Outcomes Research Team (PORT) client survey. Schizophrenia Bulletin 1998; 24: 11–20
  • Disease Management for Schizophrenia. Reston, VA: National Pharmaceutical Council, 2004.
  • Lehman AF. Public policy, community services, and outcomes for patients with schizophrenia. Psychiatric Clinics of North America 1998; 21: 221–231
  • Miller AL, Chiles JA, Chiles JK, Crismon ML, Rush AJ, Shon SP. The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms. Journal of Clinical Psychiatry 1999; 60: 649–657
  • Toprac MG, Rush AJ, Conner TM, et al. The Texas Medication Algorithm Project Patient and Family Education Program: a consumer-guided initiative. Journal of Clinical Psychiatry 2000; 61: 477–486
  • Texas Implementation of Medication Algorithms. Texas Department of State Health Services. Available at: http://www.dshs.state.tx.us/mhprograms/TIMA.shtm [last accessed 22 October 2006].
  • Lieberman JA, Stroup TS, McEvoy JP, et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 2005; 353: 1209–1223
  • Colorado launches ambitious Medicaid DM demo. Disease Management News 2003; Jan 10: 1,4–6
  • Kongstvedt PR. Essentials of Managed Care 5th edition. Jones and Bartlett Publishers, Boston, MA 2007
  • McDonald M, Hertz RP, Lustik MB, Unger AN. Healthcare spending among community-dwelling adults with schizophrenia. American Journal of Managed Care 2005; 11((8 Suppl))S242–S247
  • Dehejia RH, Wahba S. Propensity score-matching methods for non-experimental causal studies. Review of Economic and Statistics 2002; 84: 151
  • Baser O. Too much ado about propensity score models? Comparing methods of propensity score matching. Value in Health 2006; 9: 377–385
  • Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. Journal of the American Statistical Association 1984; 79: 516–524
  • D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in Medicine 1998; 17: 2265–2281
  • Fishman PA, Goodman MJ, Hornbrook MC, et al. Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Medical Care 2003; 41: 84–99
  • Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. Journal of Clinical Epidemiology 1992; 45: 197–203
  • Clark DO, Von Korff M, Sauders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Medical Care 1995; 33: 783–795
  • Leuven E, Sianesi B. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing,Version 1.2.3. Stata Corp., College Station, TX 2003
  • Skrepnek GH. Regression methods in the empiric analysis of health care data. Journal of Managed Care Pharmacy 2005; 11: 240–251
  • Cohen J. Statistical Power Analysis for the Behavioral Sciences2nd edition. Lawrence-Erlbaum Associates, Hillsdale, NJ 1988
  • Skrepnek GH. Cost-effectiveness analysis. Principles of PharmacoEconomics 3rd edition, JL Bootman, RJ Townsend, WF McGhan. W Harvey Whitney Books Company, Cincinnati, OH 2005; 83–116
  • Salkever D, Domino ME, Burns BJ, et al. Assertive community treatment for people with severe mental illness: the effect on hospital use and costs. Health Services Research 1999; 34: 577–601
  • Kuno E, Rothbard AB, Sands RG. Service components of case management which reduce inpatient care use for persons with serious mental illness. Community Mental Health Journal 1999; 35: 153–167
  • Miller AL, Crismon ML, Rush AJ, et al. The Texas medication algorithm project: clinical results for schizophrenia. Schizophrenia Bulletin 2004; 30: 627–647
  • Kashner TM, Rush AJ, Crismon ML, et al. An empirical analysis of cost outcomes of the Texas Medication Algorithm Project. Psychiatric Services 2006; 57: 648–659
  • Eaddy M, Grogg A, Locklear J. Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population. Clinical Therapeutics 2005; 27: 263–272
  • Busch AB, Frank RG, Lehman AF. The effect of a managed behavioral health carve-out on quality of care for Medicaid patients diagnosed as having schizophrenia. Archives of General Psychiatry 2004; 61: 442–448
  • Wallace NT, Bloom JR, Hu TW, Libby AM. Medication treatment patterns for adults with schizophrenia in Medicaid managed care in Colorado. Psychiatric Services 2005; 56: 1402–1408
  • Dilman DA. Mail and Telephone Surveys: the total design method. John Wiley and Sons, New York, NY 1978
  • Campbell DT, Stanley JC. Experimental and Quasi-Experimental Designs for Research. Houghton Mifflin Company, Boston, MA 1963

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.